SU1297864A1 - Method of treatment of non-specific ulcerative colitis - Google Patents

Abstract

In order to shorten the treatment time for patients with nonspecific ulcerative colitis, simultaneously with the prescription of anti-inflammatory, hormonal and vitamin preparations, an additional immunoglobulin is administered in a dose of 5-10 ml 3-5 times every other day. eo

Description

The invention relates to medicine, namely to a gastroenterologist, and can be used in the treatment of nonspecific ulcerative colitis.

The aim of the invention is to reduce the duration of treatment due to the additional administration of immunoglobulin in a specific dose according to a specific scheme.

The method is carried out as follows.

Immunoglobulin in a dose of 5 to 10 ml is administered 3–5 times a day along with the administration of anti-inflammatory, hormonal, and vitamin preparations to patients with nonspecific ulcerative colitis.

Example, Patient L., 25 years old., Was admitted to the clinic with complaints of blood excretion during defecation, penis. loose stools, weakness. The mushy stool did not consult a doctor for two months. After referring to the proctologist, he was diagnosed with hemorrhoids. The condition after treatment did not improve. The patient was admitted to the infectious disease ward ,,

At admission: blood pressure 110/70 mm Hg, the skin is clean. The tongue is moist, clean, the belly is soft, slightly swollen, moderate soreness in the region of sigma .. The chair is mushy with an admixture of blood and mucus.

According to a coprological study: visually mucus, blood, the reaction to the blood is sharply positive. Muscle fibers are single, uninterrupted fiber in large quantities. Erythrocytes fresh in large quantities. Cylindrical epithelium in significant quantities.

According to bacteriological examination of feces: the total amount of E. coli 143 million, 1.0 g, lactose-negative enterobacteria 8%, 10

Editor I. Shulla

Compiled by L. Pashuk

Tehred L. Serdyukova Proofreader I. Muska

839/7

Circulation 596. Subscription VNIIPI USSR State Committee

for inventions and discoveries P3035, Moscow, Zh-35, Raushsk nab., d, 4/5

Production and printing company, Uzhgorod, st. Project, 4

five

0

five

0

five

hemolytic E. coli. Hemolyzing staphylococcus relative to all cocci forms 40%. According to sigmoidoscopy; inspected 25 cm, in the inspected area of the mucous membrane, the hyperemic, granular, contact bleeds, in the distal part there are numerous sounds.

Diagnosed with non-specific ulcerative colitis - proctosigmoiditis.

. The treatment was carried out according to the standard scheme. Additionally prescribed administration of immunoglobulin at a dose of 5 ml 3 times every other day. After a month of stay in the hospital, a re-stenomanoscopy was repeated: the mucous was pale, single sounds, in the epithelialization stage. Bacterio-logical examination of feces was performed: the total amount of E. coli 431 million in 1.0 g. Lacto-negative enterobacteria 10%. Hemolyzing staphylococcus relative to all cocci forms 30%.

Conclusion: non-specific ulcerative colitis in remission. After two weeks, the patient's condition improved, there was no abdominal pain, no blood in the feces. The patient was discharged with improvement. Recommendations are given

On average, the duration of treatment of patients is 48.56 days according to the proposed method, compared to 57.92 days according to the known method.

Claims (1)

Formula invented and 40 A method of treating nonspecific ulcerative colitis by administering anti-inflammatory, hormonal, vitamin preparations, characterized in that, in order to shorten the treatment time, an additional immunoglobulin is administered in a dose of 5-10 ml 3-5 times every other day.